FARMACEUTICALRX Announces Certification to Commence Operation of Its Ohio Medical Marijuana Cultivation Business Becoming One of the Largest Fully Vertical - Multi-State Producers of Premium Organic Medical Marijuana Products in the US Market

PITTSBURGH, Feb. 2, 2022 /PRNewswire/ -- FARMACEUTICALRX ("FARMACEUTICALRX" or the "Company"), one of the largest producers of premium organic medical marijuana products in the US market, announced today that the Company has received final certification to commence operations as a medical marijuana cultivator from the Ohio Department of Commerce. This approval makes FARMACEUTICALRX a vertically integrated operator in Ohio. The FARMACEUTICALRX of Ohio Level 1 medical marijuana cultivation business is co-located with the Company's medical marijuana processing facility in East Liverpool, Ohio, where the Company also operates its FRX Health dispensary.

"We are excited to commence cultivation operations in Ohio," stated Rebecca Myers, Founder and CEO of FARMACEUTICALRX. "We are now a full vertically integrated operator in Ohio. We are building on the strong momentum and success of our FARMACEUTICALRX of PA grower/processor business and of our highly-rated Ohio dispensary and recently launched Ohio processing business," Myers continued. "We are now one of the largest producers of premium organic medical marijuana products in the nation. We anticipate our first harvest in Ohio in Q2 of 2022. The Ohio market is growing rapidly, and there is strong demand for our products. We are already receiving pre-order requests for our premium organic FARMACEUTICALRX branded flower, live resin and live solventless products. This critical step positions us to continue to build our FARMACEUTICALRX brand together with our suite of sub-branded products and to expand and serve our loyal customer base across Ohio and Pennsylvania," Myers stated.

ABOUT FARMACEUTICALRX.
FARMACEUTICALRX is the leading producer of premium organic medical marijuana products and the sole multi-state, vertically integrated producer of premium organic medical marijuana products in the US Market. FARMACEUTICALRX is focused on bringing research and development-based innovation to the medical marijuana sector. FARMACEUTICALRX develops premium organic medical marijuana products under its existing FARMACEUTICALRX brand. The Company's suite of sub-branded products includes Burst of Wellness Vape products, TreePharm Vape and RSO products, Local Edibles Chocolates, and Open Mind organic, vegan and gluten free gummies. Our suite of sub-branded products combines the premium quality that FARMACEUTICALRX is known for, at a lower price point, with the goal of expanding the Company's reach to a broader demographic of patients. The FARMACEUTICALRX affiliated companies are licensed to offer high quality medical marijuana products in Pennsylvania and Ohio, states with combined populations of more than 26 million people. FARMACEUTICALRX is led by a world-class team of scientists, healthcare, organic food and beverage and cannabis industry professionals who are driven by the discovery, development, and manufacturing of revolutionary, premium organic products delivered through its vertically integrated platform. From the Farm to the Future - Our innovation is Your Future Health. Learn more at www.FARMACEUTICALRX.com.

Forward-Looking Statements
This news release includes forward-looking information and statements, which may include, but ‎are not limited to, information and statements regarding or inferring the future business, ‎operations, financial performance, prospects, and other plans, intentions, expectations, estimates, ‎and beliefs of the Company. Words such as "expects", ‎‎"continue", "will", "anticipates" and "intends" or similar expressions are intended to identify ‎forward-looking statements. These forward-looking statements are based on the Company's ‎current projections and expectations about future events and financial trends that management ‎believes might affect its financial condition, results of operations, business strategy and financial ‎needs, and on certain assumptions and analysis made by the Company in light of the experience ‎and perception of historical trends, current conditions and expected future developments and ‎other factors management believes are appropriate. Forward-looking information and statements ‎involve and are subject to assumptions and known and unknown risks, uncertainties, and other ‎factors which may cause actual events, results, performance, or achievements of the Company ‎to be materially different from future events, results, performance, and achievements expressed ‎or implied by forward-looking information and statements herein. Although the Company ‎believes that any forward-looking information and statements herein are reasonable, in light of ‎the use of assumptions and the significant risks and uncertainties inherent in such information ‎and statements, there can be no assurance that any such forward-looking information and ‎statements will prove to be accurate, and accordingly readers are advised to rely on their own ‎evaluation of such risks and uncertainties and should not place undue reliance upon such ‎forward-looking information and statements. Any forward-looking information and statements ‎herein are made as of the date hereof, and except as required by applicable laws, the Company ‎assumes no obligation and disclaims any intention to update or revise any forward-looking ‎information and statements herein or to update the reasons that actual events or results could or ‎do differ from those projected in any forward looking information and statements herein, whether ‎as a result of new information, future events or results, or otherwise, except as required by ‎applicable laws.‎ 

Investor Contact
For further information, contact:
[email protected]

Media Contact:
Rebecca Myers
724-655-3335

SOURCE FARMACEUTICALRX LLC